1187 related articles for article (PubMed ID: 21063998)
1. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine].
Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L
Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
[TBL] [Abstract][Full Text] [Related]
3. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
Levy C; Taha MK; Bingen E; Cohen R;
Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
[TBL] [Abstract][Full Text] [Related]
4. [Meningococcemia: Different Serotypes in the Same Region].
Aladağ Çiftdemir N; Duran R; Vatansever Özbek Ü; Hançerli Törün S; Acunaş B; Ünal Şahin N
Mikrobiyol Bul; 2020 Jan; 54(1):163-170. PubMed ID: 32050887
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal disease.
Memish ZA; Alrajhi AA
Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
[TBL] [Abstract][Full Text] [Related]
6. Bacterial meningitis in children in southern Ghana.
Commey JO; Rodrigues OP; Akita FA; Newman M
East Afr Med J; 1994 Feb; 71(2):113-7. PubMed ID: 7925039
[TBL] [Abstract][Full Text] [Related]
7. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases.
Faye A; Mariani-Kurkdjian P; Taha MK; Angoulvant F; Antonios M; Aubertin G; Soussan V; Bingen E; Bourrillon A
Clin Infect Dis; 2004 Jun; 38(11):1635-7. PubMed ID: 15156454
[TBL] [Abstract][Full Text] [Related]
9. [Healthcare-associated Neisseria meningitidis W135 conjunctivitis].
Unal Yılmaz G; Alkan M; Vatansever Özbek U; Tuğrul HM
Mikrobiyol Bul; 2013 Oct; 47(4):722-6. PubMed ID: 24237442
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.
Soriano-Gabarró M; Toé L; Tiendrebeogo SR; Nelson CB; Dabal M; Djingarey MH; Plikaytis B; Rosenstein N;
Vaccine; 2007 Sep; 25 Suppl 1():A92-6. PubMed ID: 17517451
[TBL] [Abstract][Full Text] [Related]
11. Emergence of W135 meningococcal meningitis in Ghana.
Forgor AA; Leimkugel J; Hodgson A; Bugri A; Dangy JP; Gagneux S; Smith T; Pluschke G
Trop Med Int Health; 2005 Dec; 10(12):1229-34. PubMed ID: 16359402
[TBL] [Abstract][Full Text] [Related]
12. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of meningococcal meningitis in children in France].
Levy C; Taha MK; Weill Olivier C; Quinet B; Lécuyer A; Alonso JM; Cohen R; Bingen E;
Arch Pediatr; 2008 Dec; 15 Suppl 3():S105-10. PubMed ID: 19268239
[TBL] [Abstract][Full Text] [Related]
14. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
[TBL] [Abstract][Full Text] [Related]
15. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
16. Clonal spread of serogroup W135 meningococcal disease in Turkey.
Kilic A; Urwin R; Li H; Saracli MA; Stratton CW; Tang YW
J Clin Microbiol; 2006 Jan; 44(1):222-4. PubMed ID: 16390974
[TBL] [Abstract][Full Text] [Related]
17. Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001).
Caniça M; Dias R; Nunes B; Carvalho L; Ferreira E; The Meningococci Study Group
J Med Microbiol; 2004 Sep; 53(Pt 9):921-925. PubMed ID: 15314201
[TBL] [Abstract][Full Text] [Related]
18. [Failure of the treatment with penicillin in a case of Neisseria meningitidis meningitis].
Bardi L; Badolati A; Corso A; Rossi MA
Medicina (B Aires); 1994; 54(5 Pt 1):427-30. PubMed ID: 7658978
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
[TBL] [Abstract][Full Text] [Related]
20. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
